Enhanced MRI Imaging without Gadolinium
Redefining brain medical imaging precision. Our AI-driven technology eliminates Gadolinium dyes with 95% accuracy, making brain tumor treatment safer, more affordable, and saving 100 minutes per patient visit.
0
Cases Processed
0
Clinical Trial Cases
0
Registered Patents
0
Hospitals Onboard
A Breakthrough in
Brain Medical Imaging
Pixelence is disrupting the way brain medical imaging is done by eliminating the use of Gadolinium using prediction with 95% accuracy from the process. This breakthrough makes brain tumor treatment more affordable and safer.
-
No Gadolinium Required
Eliminates the risks associated with heavy metal contrast dyes.
-
Time Efficient
Saves up to 100 minutes of patients' and hospitals' time on every single visit.
-
High Accuracy
Synthetic generation with over 95% predicted accuracy for critical diagnoses.
Our Focus Areas
Targeted diagnostics for the most critical brain medical conditions.
Brain Tumours
Advanced synthetic imaging for early tumor detection and precise boundary rendering, completely eliminating the need for invasive Gadolinium contrast dyes.
Strokes
High-contrast, precision scans isolating ischemic and hemorrhagic stroke zones instantly, providing necessary critical clarity for rapid, life-saving emergency interventions.
Trauma Cases
Extremely fast predictive reconstruction of brain matter and tissue mapping, delivering crisp diagnostic imaging for severe traumatic brain injuries right at the point of care.
How Pixelence Works
A seamless integration into the clinical workflow, from capture to final report.
Our Featured Peer-Reviewed Publication
"General adversarial neural networks may generate diagnostic quality contrast-enhanced structural MRI from structural non-contrast T1." This breakthrough study demonstrates that our AI core can be applied retrospectively across varied clinical cases, validating the generation of safe, Gadolinium-free medical imaging without loss of diagnostic precision.
Read Full Article →Join the Future of Medical Imaging
Sign up to get the latest updates on our European Incubation and Development Centre activities.
